Thrombosis Update, 2:100030. Elsevier BV Thrombosis Update, Vol 2, Iss, Pp 100030-(2021) Kraaijpoel, N, Mulder, F I, Carrier, M, van Lieshout, A, Würdinger, T, Best, M G, van Vlijmen, B J M, Mohammed, Y, Jara-Palomares, L, Kamphuisen, P W, di Nisio, M, Ageno, W, Beyer-Westendorf, J, Vanassche, T, Klokm, F A, Otten, H-M, Peters, M J L, Cosmi, B, Wolde, M T, Bossuyt, P M M, Büller, H R & van Es, N 2021, ' Novel biomarkers to detect occult cancer in patients with unprovoked venous thromboembolism : Rationale and design of the PLATO-VTE study ', Thrombosis Update, vol. 2, 100030 . https://doi.org/10.1016/j.tru.2020.100030
Blood, 132(21), 2298-2304. AMER SOC HEMATOLOGY Blood, 132, 21, pp. 2298-2304 Blood, 132(21), 2298-2304. American Society of Hematology Amin, E E, Bistervels, I M, Meijer, K, Tick, L W, Middeldorp, S, Mostard, G, van de Poel, M, Serné, E H, Otten, H M, Klappe, E M, Joore, M A, ten Cate, H, ten Wolde, M & ten Cate-Hoek, A J 2018, ' Reduced incidence of vein occlusion and postthrombotic syndrome after immediate compression for deep vein thrombosis ', Blood, vol. 132, no. 21, pp. 2298-2304 . https://doi.org/10.1182/blood-2018-03-836783 Blood, 132, 2298-2304 Blood, 132(21), 2298-2304. The American Society of Hematology
ten Cate-Hoek, A J, Amin, E E, Bouman, A C, Meijer, K, Tick, L W, Middeldorp, S, Mostard, G J M, ten Wolde, M, van den Heiligenberg, S M, van Wissen, S, van de Poel, M H W, Villalta, S, Serné, E H, Otten, H M, Klappe, E H, Bistervels, I M, Lauw, M N, Piersma-Wichers, M, Prandoni, P, Joore, M A, Prins, M H & ten Cate, H 2018, ' Individualised versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome (IDEAL DVT) : A multicentre, randomised, single-blind, allocation-concealed, non-inferiority trial ', The Lancet Haematology, vol. 5, no. 1, pp. e25-e33 . https://doi.org/10.1016/S2352-3026(17)30227-2 Lancet Haematology, 5(1), 25-33. ELSEVIER SCI LTD The Lancet Haematology, 5(1), e25-e33. Lancet Publishing Group Lancet Haematology, 5, 1, pp. 25-33 The Lancet Haematology, 5(1), 25-33. ELSEVIER SCI LTD Lancet. Haematology, 5(1), e25-e33. Lancet Publishing Group Lancet Haematology, 5, 25-33